skip to Main Content

In 2018, the UN High-Level Meeting on the Fight Against Tuberculosis and the resulting Political Declaration codified commitments made by country governments to scale-up the global TB response by mobilizing resources towards ambitious targets. Support for TB research and development (TB R&D) continues to be a critical pillar of the declaration, the Stop TB Partnership Global Plan, and the World Health Organization Global Strategy for TB Research and Innovation.

Yet the world remains woefully behind in meeting global funding targets for TB R&D. Public funders (i.e., governments) remain the largest source of funding for TB R&D and play an important role in supporting science for new TB treatments, diagnostics, and vaccines. New tools across all these categories of research are needed, and increasing government TB R&D funding remains a critical step to successfully realizing lifesaving innovations for TB treatment, diagnosis, and prevention.

Treatment Action Group (TAG) engages in strategic advocacy to catalyze government commitments and political will for increased TB R&D funding and enabling policies. In addition to publishing an annual report tracking TB research funding trends, TAG has further devised a strategic methodology to split the global TB research funding target into country-level targets through a ‘fair-share’ approach based on resources currently spent on R&D. TAG is also increasing its focus on TB vaccines, as highlighted in a recent brief on the need for greater European investments to TB vaccine R&D. Building on success in the United States and initial work in the European region in advocating for increased TB R&D funding, TAG is aiming to expand that advocacy. TAG now hopes to target governments of the European Union (EU) and other G20 countries that are well-poised to grow their commitments to TB R&D and overcome the annual funding gap.

About TAG
TAG is an independent, activist and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for HIV, tuberculosis, and hepatitis C virus. At TAG, we strive to reflect in our organizational composition and operations the values, principles, and rights for which we advocate externally. This includes a commitment to equity and justice, as well valuing diversity of experience, in our employment practices. We encourage Black, indigenous, and people of color; women; transgender, nonbinary, and gender nonconforming people; veterans; and people with disabilities to apply.

TAG is seeking a consultant to advance strategic policy advocacy and resource mobilization efforts for TB R&D, specifically for new TB vaccines and by positioning TB within global efforts to curb anti-microbial resistance (AMR). The consultant will be responsible for monitoring relevant institutional developments, engaging policymakers, investigating legislative opportunities, and executing advocacy strategies in collaboration with TAG and allied organizations to increase TB R&D resources in donor countries, focusing on the European region and other strategic G20 and G7 countries. This consultancy is based in Europe.

The consultant will serve as a strategic partner and liaison between the TAG Policy and TB Project teams on R&D funding issues. The consultant will work and communicate closely with both teams on key developments in the European political landscape, as well as the G7 and G20, conducive to expanding TB R&D funding. This work includes representing TAG and facilitating collaboration between a range of partners including civil society, academia, and advocacy coalitions. The consultant will have access to published TAG resources to inform strategy and will support the development and dissemination of additional advocacy tools needed to catalyze further action on TB R&D in Europe and globally.

Qualified candidates will have strong experience in global health advocacy and policy issues, as well as expertise in navigating political systems of EU member states and the EU, such as the European Commission. Experience and understanding of one or more country government political dynamics – e.g., UK, Denmark, France, Germany, Ireland, The Netherlands, or Norway – is a plus, as well as knowledge of engaging with member states of the G7 and G20. Candidates will work within coalitions such as the TB Vaccine Advocacy Roadmap (TB Vax ARM), the European Alliance for Responsible R&D and Affordable Medicines (the Alliance), and the Global TB Caucus (GTBC), as well as with national and international partners such as Deutsche Stiftung Weltbevölkerung, the International AIDS Vaccine Initiative, RESULTS UK, and the Stop TB Partnership, among others.

Reporting: U.S. and Global Health Policy Director, with collaborative support from the TB Project Co-Directors

Total Budget: USD $18,000  to $20,000.


  • June/July 2022 to December 2022 (extension through April 2023 contingent on availability of funding)
  • Expected weekly time commitment: 8-10 hours/week

Key Tasks:

  • Collaborate with TAG on a strategic plan and timeline for TB R&D advocacy, particularly on financial commitments to R&D for TB vaccine development and embedding TB R&D in the European/global agenda to address AMR.
  • Help coordinate activities of the TB Vax ARM, a coalition of civil society organizations advocating for new TB vaccines.
  • Manage partnerships with relevant allied organizations and coalitions operating within the global and European advocacy space, including the TB Vax ARM, the Alliance, DSW and the GTBC among others, and work collaboratively to advance TB R&D priorities and commitments for European R&D funding mechanisms, particularly Horizon Europe, EDCTP, and HERA.
  • Develop messaging, presentations, and briefing papers for policymaker and stakeholder education; with support from TAG Communications Team, identify media opportunities for advocacy messages with wider European audiences; hold trainings with civil society stakeholders to capacitate and strategize on advocacy for expanding TB R&D.
  • Ascertain potential partners, extrapolate and apply strategies for advocacy with target EU member governments that are well positioned to increase TB R&D spending such as Denmark, France, Germany, Ireland, The Netherlands, or Norway, where appropriate.
  • Engage in relevant political processes, such as the G7/G20 and EU Presidencies, to promote TB R&D and increased European investments.
  • Monitor European policy and legislative environment regarding R&D cooperation policies, especially those related to health.
  • Forge relationships with allies within national European governments, the European parliament, and the GTBC.
  • Identify advocacy opportunities, events, and activities to be carried out to promote increased European and G20 and G7 TB R&D investments; coordinate activities with support from the TAG Policy and TB Project teams.


Qualifications and Requisite Experience:

  • Strong interest in global health and development policy issues.
  • 3-5 years of work experience in European advocacy, research, health and rights, or similar development issues.
  • Deep knowledge and understanding of EU structures and decision making, financial instruments, and EU development policies. Knowledge of individual EU member state government processes and policies a plus.
  • Experience with Brussels policy arena and the role played by NGOs in the policy process and resource mobilization efforts in the EU.
  • Specific knowledge of TB funding and research issues a plus.
  • Proven track record in networking and working in coalitions and alliances to build consensus around shared advocacy goals.
  • Although not required, lived experience with TB will be considered.


  • Sharp interpersonal skills; ability to interact with diverse groups and to communicate effectively with officials, policymakers, stakeholders, and civil society on the importance of TB R&D.
  • Strong verbal communication skills and the ability to work with a team, including consistent communication and regular follow-up with teams based in the U.S. (New York City and Washington, D.C.).
  • Excellent writing and verbal skills in English; fluency in another EU language (e.g., French, German, Portuguese) is a plus but not required.
  • Public-speaking skills; ability to speak in meetings and conferences to posit interventions and ad-hoc opportunities for advocacy.
  • Strategic skills; ability to capitalize on policy and funding opportunities and navigate complex government systems.
  • Policy analysis skills; ability to maintain and analyze a portfolio of policies and legislation for advocacy.
  • Eagerness and willingness to learn quickly and adapt to new challenges with a rapidly changing policy and political environment.
  • Demonstrate initiative and ability to work independently and as part of a team.
  • Strong commitment to human rights, social justice, and diversity.
  • Willing to travel, should COVID-19 travel restrictions allow.

How to apply:

  • Expressions of interest can be sent via email to, with “TB R&D Advocacy Consultant” in the subject line.
  • Expressions of interest should include:
    • 1 page cover letter
    • Curriculum vitae (CV)
    • 3 professional references
    • Writing sample (5 pages max.)

Applications will be reviewed on a rolling basis, with a consultancy starting in June/July 2022.

Treatment Action Group is an equal opportunity employer and does not discriminate on the basis of sexual orientation, gender identity or expression, race, color, religion, national origin, sex, age, marital status, disability, personal appearance, family responsibility, political affiliation or any other status protected by applicable law. People of color; women; transgender, nonbinary, and gender nonconforming people; veterans; and people with disabilities are encouraged to apply. People with lived experience with TB are strongly encouraged to apply.

Back To Top